Pharmac Message on Mesalazine Tablets
Posted Wednesday September 3, 2025
From 1 July 2025 Pharmac listed Mesalazine 1600mg tablets, Asacol brand.
Due to the current shortage of mesalazine 400mg tablets please consider prescribing mesalazine 1600mg for patients that are taking a 1600mg dose.
This is a Section 29 (unapproved) medicine.
Additional information can be found here - Mesalazine tablets Pharmac website
Gallery
Related Articles
Gut Foundation encourages you to Talk sh*t. Save lives.
Friday May 8, 2026
May is Good Gut Month, and we're backing Gut Check, a new campaign from The Gut Foundation to get Kiwis talking about th...
Join the RACP Regional, Rural, and Remote Physician Special Interest Group
Wednesday May 6, 2026
Expressions of interest are invited from members to join the Regional, Rural, and Remote Physician Special Interest Grou...